| Primary information |
|---|
| ID | 16053 |
| Uniprot ID | P01213 |
| Description | Angiotensinogen (Serpin A8) [Cleaved into- Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (A |
| Organism | Homo sapiens |
| Txonomy | Ovis ; Caprinae ; Bovidae ; Pecora ; Ruminantia ; Artiodactyla ; Laurasiatheria ; Boreoeutheria ; Eutheria ; Theria ; Mammalia ; Amniota ; Tetrapoda ; Dipnotetrapodomorpha ; Sarcopterygii ; Euteleostomi ; Teleostomi ; Gnathostomata ; Vertebrata ; Craniata ; Chordata ; Deuterostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | NA |
| Similarity | Opioid neuropeptide precursor family |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions; including pain perception and responses to stress |
| Length | 476 |
| Molecular Weight | 51 |
| Name | Leu-enkephalin |
| Sequence | YGGFL |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | P41145; P35372; P41143; Q05586; Q12879; Q13224; Q14957; P41145; P35372; P41143; P41145; P35372; P411 |
| Domain | NA |
| Pharmaceutical Use | NA
|